RECENT NEWS

NEWSMAX: Diabetes Takes a Toll on Your Wallet as Well as Your Health

When we think of diabetes, what comes to mind is diet, insulin injections, obesity, and even heart disease. But diabetes doesn’t just affect a person’s health; it can be incredibly expensive.

THE HILL: Diabetes research at risk due to funding lapse, groups warn

Several groups are pleading with Congress to permanently fund diabetes programs, arguing the absence of long-term funding could delay promising new research and harm prevention efforts in vulnerable populations.   

KECI: Specialist warns diabetes is dealing Montana a powerful blow

Figures from the American Diabetes Association and Providence Health Services show diabetes is dealing Montana a powerful blow.

Fox Business: HHS Nominee Oversaw Big Drug Price Increases at Lilly

President Donald Trump said in a tweet Monday that his nominee for secretary of Health and Human Services will be a “star” for his ability to lower drug prices.

Drug Topics: As Diabetes Numbers Rise, Costs Mount

Diabetes treatment has seen sweeping changes in recent years, as more patients are diagnosed, and as the estimated cost to Americans—$245 billion in 2012—continues to rise.

Houma Today: Federal and state probes target rising cost of diabetes drugs

With the price of a crucial diabetes drug skyrocketing, at least five states and a federal prosecutor are demanding information from insulin manufacturers and the pharmaceutical industry’s financial middlemen.

Nuvo: Indiana has a drug (company) problem: Insulin is increasingly inaccessible for those who need it

It is a bright and sunny autumn Saturday afternoon. Across Indiana, people gather on the sidelines of kids’ soccer games and tailgate outside of college football stadiums.

Healthcare Finance: Soaring insulin prices prompt federal and state investigations into drugmakers, pharma

With the price of a crucial diabetes drug skyrocketing, at least five states and a federal prosecutor are demanding information from insulin manufacturers and the pharmaceutical industry’s financial middlemen.

WJTV 12: Diabetes supply cost puts strain on patients and companies

Experts say increasing diabetes supply cost is putting a strain on patients and companies.

News Press Now: Insulin costs burdening patients

Ever-increasing costs for lifesaving insulin are starting to fuel desperation among at least a portion of those with Type-1 diabetes.

WWLP 22 News: The high price of staying alive

The EpiPen isn’t the only drug that’s seen a massive price hike in recent months.